Steve, I don't think I have much to add. Maybe Nikhil has something to add after I'm done. I would just tell you that this is sort of the only time I've seen where there's opportunity in all three product types across all three countries, right? You usually don't see that. And that's driven by -- last couple of years have been primarily debt driven, right? So, we have seen a lot of opportunities in the IRR. So, we have done senior housing 9%, call it circa, 9%, some higher, some lower, but call it around 9%. Historically, I've said medical office is an interesting business to buy or interesting space to invest around, call it, 7-plus unlevered IRR. Finally, we're seeing opportunities in 8-plus level. And on the wellness side, where the cap rates have been very, very tight, IRRs have been in the 6s, we're finally seeing they're in the high-7s, right? So, that's sort of, I would say, where the different investment landscape where we're seeing opportunities, but depends on -- some are obviously higher. We're still seeing some double-digit opportunities. But I will tell you the other thing is because it's not just debt driven but also equity driven, most of the stuff that we have bought in last couple of years, we're fundamentally focused on right location, right product, right basis. And we have bought lots of assets with no cash flow, negative cash flow. And finally, we're seeing because people have to transact, right, what's happening, we are seeing opportunities that with very good bases, with very good locations, assets are also starting to come with cash flow. That's sort of, I will say, the slight change in nuance of the investment landscape. But I don't know, Nikhil you want to add anything?